reports
Taysha Gene Therapies Reports Second Quarter 2025 Financial Results an...
Taysha Gene Therapies Reports Second Quarter 2025 Financial Results and Provides Corporate Update Commenced site activation for REVEAL pivotal trial in accordance with previously aligned upon key design elements, following receipt of No Objection Letter (NOL) from Health Canada and feedback from the FDA; patient enrollment anticipated to begin in Q4 2025 High dose and low dose TSHA-102 continue to be generally well tolerated with no treatment-related SAEs or DLTs in the 12 patients treated in Part A of REVEAL Phase 1/2 trials as of August 2025 data cutoff Part A data from REVEAL Phase 1/2...
Centessa Pharmaceuticals Reports Financial Results and Business Highli...
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2025 Advancing a broad, potential best-in-class orexin receptor 2 (OX2R) agonist franchise, with key data readouts expected this year ORX750 Phase 2a CRYSTAL-1 study for the treatment of narcolepsy type 1 (NT1), narcolepsy type 2 (NT2) and idiopathic hypersomnia (IH) on track with data expected in all three indications this year with first-in-class potential in NT2 and IH ORX142 Phase 1 clinical trial for the treatment of select neurological and neurodegenerative disorders underway with d...
Enphase Energy Continues Global Rollout of IQ Battery 5P with FlexPhas...
Enphase Energy Continues Global Rollout of IQ Battery 5P with FlexPhase in Australia FREMONT, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the launch of the IQ® Battery 5P™ with FlexPhase for customers in Australia. The IQ Battery 5P with FlexPhase is an all-in-one AC-coupled system that delivers reliable backup power and supports both single-phase and three-phase applications with variable power levels, offering flexibility to meet diverse ho...
Taysha Gene Therapies to Release Second Quarter 2025 Financial Results...
Taysha Gene Therapies to Release Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 12 DALLAS, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that it will report its financial results for the second quarter ended June 30, 2025, and host a corporate update conference call and webcast on Tuesday, August 12, 2025, ...
Enphase Energy Announces New Safe Harbor Agreement
Enphase Energy Announces New Safe Harbor Agreement FREMONT, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced a new safe harbor agreement with a solar and battery financing company that offers third-party ownership (TPO) agreements to homeowners, including leases and power purchase agreements (PPAs). The safe harbor agreement covers Enphase’s U.S.-manufactured IQ8HC™ Microinverters (with “DOM” SKUs), helping future projects preserve eligibility fo...
Enphase Energy Announces SDG&E Approval of IQ Meter Collar, Simplifyin...
Enphase Energy Announces SDG&E Approval of IQ Meter Collar, Simplifying Home Backup for More Californians FREMONT, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced that San Diego Gas & Electric (SDG&E) has approved the for behind-the-meter installations in its service territory. This milestone approval enables installers to deliver more streamlined home backup systems, with quicker installation, to customers in the SDG&E service territory. The I...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing ...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) DALLAS, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on August 1, 2025, the Compensation Committee of Taysha's Board of Directors granted one new employee an option to purchase 90,000 shares of the Company's common stock in connection with their employm...
Enphase Energy Launches Next-Generation Battery System for Smarter, Si...
Enphase Energy Launches Next-Generation Battery System for Smarter, Simpler Home Power FREMONT, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the launch of the 4th-generation Enphase® Energy System, featuring the IQ® Battery 10C, IQ® Meter Collar, and the IQ® Combiner 6C. This next-generation system stands out for its smaller footprint, enhanced features, easier installation, and unmatched reliability. Watch a video about the new Enphase system...
Meridian Corporation Reports Second Quarter 2025 Results and Announces...
Meridian Corporation Reports Second Quarter 2025 Results and Announces a Quarterly Dividend of $0.125 per Common Share MALVERN, Pa., July 24, 2025 (GLOBE NEWSWIRE) -- Meridian Corporation (Nasdaq: MRBK) today reported: Three Months Ended(Dollars in thousands, except per share data) (Unaudited)June 30, 2025 March 31, 2025 June 30, 2024Income: Net income$5,592 $2,399 $3,326Diluted earnings per common share 0.49 0.21 0.30Pre-provision net revenue (PPNR) (1) 11,090 8,357 7,072(1) See Non-GAAP reconciliation in the Appendix Net income for the quarter ended June 30, 2025 w...
Enphase Energy Continues Expanding Product Offering in Europe with IQ8...
Enphase Energy Continues Expanding Product Offering in Europe with IQ8P Microinverter Launch in Italy and Switzerland FREMONT, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced that it is continuing to expand its product offering in Europe to meet the needs of customers with initial shipments of IQ8P™ Microinverters, with peak output AC power of 480 W, in Italy and Switzerland to support newer, high-powered solar modules. IQ8P Microinverters h...
Enphase Energy Reports Financial Results for the Second Quarter of 202...
Enphase Energy Reports Financial Results for the Second Quarter of 2025 FREMONT, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world’s leading supplier of microinverter-based solar and battery systems, announced today financial results for the second quarter of 2025, which included the summary below from its President and CEO, Badri Kothandaraman. We reported quarterly revenue of $363.2 million in the second quarter of 2025, along with 48.6% for non-GAAP gross margin. We shipped approximately 1.53 million microinverters, or 675.4 me...
Enphase Energy Begins Shipments of IQ Battery 5P with Higher Domestic ...
Enphase Energy Begins Shipments of IQ Battery 5P with Higher Domestic Content to Meet New U.S. Federal Requirements FREMONT, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced initial shipments of the IQ® Battery 5P supplied from manufacturing facilities in the United States with higher domestic content than previous models. The higher domestic content batteries comply with the new requirement in the U.S. federal budget law, signed on July 4, 2025, ...
Enphase Energy Expands IQ EV Charger 2 in Europe with New Markets, Cer...
Enphase Energy Expands IQ EV Charger 2 in Europe with New Markets, Certifications, and Smart Meter Integration FREMONT, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced that production shipments of its newest electric vehicle (EV) charger, the IQ® EV Charger 2, have expanded across Europe to now include Greece, Romania, Ireland, and Poland. The IQ EV Charger 2 is a smart charger designed to work seamlessly with Enphase solar and battery systems or...
Enphase Energy Announces Conference Call to Review Second Quarter 2025...
Enphase Energy Announces Conference Call to Review Second Quarter 2025 Financial Results Tuesday, July 22, 2025 at 4:30 p.m. Eastern Time FREMONT, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- . (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, announced today that it will host a conference call and webcast on Tuesday, July 22, 2025 at 4:30 p.m. Eastern Time to discuss its second quarter 2025 financial results for the period ended June 30, 2025. The live webcast can be accessed on the Enphase Energy Investor...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing ...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) DALLAS, July 03, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on July 1, 2025, the Compensation Committee of Taysha's Board of Directors granted two new employees, in the aggregate, options to purchase 30,000 shares of the Company's common stock in connection wi...
Enphase Energy Launches Next-Generation IQ EV Charger 2 In Australia a...
Enphase Energy Launches Next-Generation IQ EV Charger 2 In Australia and New Zealand FREMONT, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced production shipments of its newest electric vehicle (EV) charger, the IQ® EV Charger 2, in Australia and New Zealand. The IQ EV Charger 2 is a smart charger built to work seamlessly with Enphase solar and battery systems or as a powerful standalone charger. With advanced energy management features, the char...
Enphase Energy Board of Directors Affirms Re-election of Thurman John ...
Enphase Energy Board of Directors Affirms Re-election of Thurman John Rodgers as Director of the Board FREMONT, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced that its Board of Directors, excluding Thurman John (T.J.) Rodgers, unanimously voted to retain Mr. Rodgers as a member of the Board of Directors. The decision followed a recommendation of the Nominating and Corporate Governance Committee of the Board, also conducted without Mr. Rodgers’ p...
Moody's Ratings downgrades VF Corp.'s CFR to Ba2; outlook changes to n...
Moody's Ratings (Moody's) downgraded V.F. Corporation's (VF Corp.) corporate family rating (CFR) to Ba2 from Ba1 and its probability of default rating (PDR) to Ba2-PD from Ba1-PD. Additionally, we downgraded VF Corp.'s senior unsecured notes ratings to Ba2 from Ba1, senior unsecured shelf and senior...
Centessa Pharmaceuticals Announces Clearance of Investigational New Dr...
Centessa Pharmaceuticals Announces Clearance of Investigational New Drug Application (IND) for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist; Clinical Data in Acutely Sleep-Deprived Healthy Volunteers Planned for this Year BOSTON and LONDON, June 16, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the IND to initiate a Phase 1 clinical study of ORX142 in healthy volunteers. ORX142 is an investigational, novel, highly potent and selective OX2R agoni...
Enphase Energy Rolls Out IQ Battery 5P with FlexPhase, Delivering Thre...
Enphase Energy Rolls Out IQ Battery 5P with FlexPhase, Delivering Three-Phase Backup Across More European Countries FREMONT, Calif., June 16, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the launch of its most powerful and versatile battery yet, the IQ® Battery 5P™ with FlexPhase, for customers in Spain, Portugal, France, Sweden, Denmark, Belgium, and the Netherlands. The IQ Battery 5P with FlexPhase is an all-in-one AC-coupled system that delivers reliable ba...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.